← All organizations
First clinical trial
Dec 30, 2021Last known activity
Nov 1, 2024
Timeline
2010s
- Sep 3, 2019
Elevar Therapeutics— Founded
- Sep 3, 2019
LSK BioPartners Inc.— Acquired
Drugs by trial phase (6 distinct, 9 trials)
Phase 3 (0 own, 1 via acquisition)
Phase 2 (0 own, 4 via acquisition)
Phase 1 (0 own, 1 via acquisition)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (2)
- NCT06308575CollaboratorPhase 2Nov 1, 2024
- NCT05287360Lead sponsorPhase 1Dec 30, 2021
Details
- Founded
- Salt Lake City, UT, US Sep 3, 2019
- Last known activity
- Nov 1, 2024